Viewing Study NCT06698003


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT06698003
Status: RECRUITING
Last Update Posted: 2025-03-04
First Post: 2024-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module